enow.com Web Search

Search results

1. T - AT&T Inc.

   Yahoo Finance

   • News
   •  Charts
   •  Conversations

   • Range :
   • 1d
   • 5d
   • 6m
   • 1y
   • Max

   18.22+0.60 (+3.41%)

   at Fri, May 31, 2024, 4:00PM EDT - U.S. markets closed

   Nasdaq Real Time Price

   • Open 17.53
   • High 18.27
   • Low 17.47
   • Prev. Close 17.62

   • 52 Wk. High 18.27
   • 52 Wk. Low 13.43
   • P/E 9.80
   • Mkt. Cap 130.64B

   • NYSE
   • •Price in USD

2. Results from the WOW.Com Content Network

3. Adult T-cell leukemia/lymphoma - Wikipedia

   en.wikipedia.org/wiki/Adult_T-cell_leukemia/lymphoma

   A small amount of HTLV-1 individuals progress to develop ATL with a long latency period between infection and ATL development. ATL is categorized into 4 subtypes: acute, smoldering, lymphoma-type, chronic. Acute and Lymphoma-type are known to particularity be aggressive with poorer prognosis.

4. T-cell lymphoma - Wikipedia

   en.wikipedia.org/wiki/T-cell_lymphoma

   The prognosis and treatment of T-cell lymphoma can vary drastically based on the specific type of lymphoma and its growth patterns. Due to their rarity and high variability between the different subtypes, the prognosis of T-cell lymphoma is significantly worse than other Non-Hodgkin lymphoma. [1]

5. T-cell acute lymphoblastic leukemia - Wikipedia

   en.wikipedia.org/wiki/T-cell_acute_lymphoblastic...

   Although both treatments included administering high-dose methotrexate and asparaginase and allogeneic hematopoietic stem cell transplantation, high survival and low death rates were present for all patients for the first treatment whereas the latter led to a high toxic death rate amongst adults.

6. T-cell prolymphocytic leukemia - Wikipedia

   en.wikipedia.org/wiki/T-cell_prolymphocytic_leukemia

   Before the recent introduction of better treatments, such as alemtuzumab, the median survival time was 7.5 months after diagnosis. More recently, some patients have survived five years and more, although the median survival is still low.

7. Lymphoproliferative disorders - Wikipedia

   en.wikipedia.org/wiki/Lymphoproliferative_disorders

   Hematology and oncology. Lymphoproliferative disorders ( LPDs) refer to a specific class of diagnoses, comprising a group of several conditions, in which lymphocytes are produced in excessive quantities. These disorders primarily present in patients who have a compromised immune system. Due to this factor, there are instances of these ...

8. Acute lymphoblastic leukemia - Wikipedia

   en.wikipedia.org/wiki/Acute_lymphoblastic_leukemia

   Person with t(9,22) positive-ALL (30% of adult ALL cases) and other Bcr-abl-rearranged leukemias are more likely to have a poor prognosis, but survival rates may rise with treatment consisting of chemotherapy and Bcr-abl tyrosine kinase inhibitors.